Reproductive Hormones and the Menopause Transition
Section snippets
Staging the MT
The MT is preceded by approximately 35 years of regular, predictable menstrual cycles. During this time, women have a well-defined intermenstrual interval of 25 to 35 days. These cycles consist of a 14-day luteal phase, and a follicular phase of at least 10 to 11 days. Before the appearance of a break in this characteristic menstrual rhythm, the oocyte supply has been dwindling, but has not yet reached a critical level. Nonetheless, although no signs are detectable to a woman, some subtle
Menstrual Cycle Hormone Changes Across the MT
Although numerous worldwide studies have reported findings on annual or semiannual changes in serum hormones across the MT,12, 26, 27 which are usually measured in the early follicular phase of the cycle, day-to-day hormone levels across a menstrual cycle have been less well characterized.
The first studies of menstrual cycle dynamics across the MT were performed by Metcalf, from New Zealand. To characterize hormone patterns over time, these investigators developed methods suitable for the
Clinical Implications
With the maturation of SWAN and the transition to postmenopause by the vast majority of participants, both observed and obscured by hormone use or surgery, it has become possible to disentangle many of the coincident effects of both ovarian and chronologic aging on the health of women at midlife. Moreover, the complex patterns of change throughout the MT in both the cyclic and longitudinal hormone profiles are now in sharper focus and will help to direct clinical care as well as guide future
References (47)
- et al.
SWAN: a multi-center, multi-ethnic, community-based cohort study of women and the menopausal transition
- et al.
The ReSTAGE Collaboration: defining optimal bleeding criteria for onset of early menopausal transition
Fertil Steril
(2008) - et al.
Dimeric inhibin: a direct marker of ovarian aging
Fertil Steril
(1998) - et al.
Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome
Fertil Steril
(1997) The normal menopause transition: an overview
Maturitas
(1996)The endocrinology of the menopause
J Steroid Biochem Mol Biol
(1999)- et al.
Probability of menopause with increasing duration of amenorrhea in middle-aged women
Am J Obstet Gynecol
(1979) - et al.
Follicular phase hormone levels and menstrual bleeding status in the approach to menopause
Fertil Steril
(2005) - et al.
Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?
J Am Coll Cardiol
(2009) Quantitative morphological investigations of the follicular system in women; variations at different ages
Acta Anat (Basel)
(1952)
A quantitative and cytological study of germ cells in human ovaries
Proc R Soc Lond B Biol Sci
Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause
Hum Reprod
Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion
J Clin Endocrinol Metab
Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women
Hum Reprod
Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age
J Clin Endocrinol Metab
Impaired folliculogenesis and ovulation in older reproductive aged women
J Clin Endocrinol Metab
Menopause and hypothalamic-pituitary sensitivity to estrogen
JAMA
Hypothalamic-pituitary ageing: progressive increase in FSH and LH concentrations throughout the reproductive life in regularly menstruating women
Clin Endocrinol (Oxf)
Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period
J Clin Endocrinol Metab
Helping midlife women predict the onset of the final menses: SWAN, the Study of Women's Health Across the Nation
Menopause
Characterization of reproductive hormonal dynamics in the perimenopause
J Clin Endocrinol Metab
Bone mineral density changes during the menopause transition in a multiethnic cohort of women
J Clin Endocrinol Metab
Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition
J Clin Endocrinol Metab
Cited by (117)
How preclinical models of menopause can inform clinical care: A focus on midlife and reciprocal communication between clinical and preclinical science
2023, Current Opinion in Endocrine and Metabolic ResearchAre serum estrogen concentrations associated with menopausal symptom bother among postmenopausal women? Baseline results from two MsFLASH clinical trials
2022, MaturitasCitation Excerpt :Therefore, the results of this study should not be compared with studies that examined hormonal concentrations longitudinally over time (e.g., [12]). This is important because early in the menopausal transition, serum E2 concentrations fluctuate and can be intermittently elevated [26]. Moreover, VMS are experienced well before the increasing variability in cycle length of the late menopausal transition (cessation of menses for at least 60 days), highlighting the complexity of associations between serum estrogen concentrations and menopausal symptoms.
The menopausal transition period and cardiovascular risk
2024, Nature Reviews Cardiology
Funded by AG-12535 and NR-04061.
Dr Nanette Santoro is a consultant to Menogenix.